PhenylbutazoneCAS# 50-33-9 |
- Metformin HCl
Catalog No.:BCC4799
CAS No.:1115-70-4
- Lenalidomide (CC-5013)
Catalog No.:BCC2245
CAS No.:191732-72-6
- Gliclazide
Catalog No.:BCC5002
CAS No.:21187-98-4
- Geniposide
Catalog No.:BCN5104
CAS No.:24512-63-8
- MEK inhibitor
Catalog No.:BCC1738
CAS No.:334951-92-7
- Imeglimin hydrochloride
Catalog No.:BCC4085
CAS No.:775351-61-6
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 50-33-9 | SDF | Download SDF |
| PubChem ID | 4781 | Appearance | Powder |
| Formula | C7H8BrN | M.Wt | 186.0 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | DMSO : ≥ 100 mg/mL (324.29 mM) H2O : < 0.1 mg/mL (insoluble) *"≥" means soluble, but saturation unknown. | ||
| Chemical Name | 4-butyl-1,2-diphenylpyrazolidine-3,5-dione | ||
| SMILES | CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3 | ||
| Standard InChIKey | VYMDGNCVAMGZFE-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C19H20N2O2/c1-2-3-14-17-18(22)20(15-10-6-4-7-11-15)21(19(17)23)16-12-8-5-9-13-16/h4-13,17H,2-3,14H2,1H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Phenylbutazone is used as a non-steroidal anti-inflammatory agent for the treatment of chronic pain, including the symptoms of arthritis.
Target: Others
Phenylbutazone was originally made available for use in humans for the treatment of rheumatoid arthritis and gout in 1949. However, when combined with paracetamol and many other household painkillers even in the smallest doses can cause irreversible liver degradation proving fatal in many cases. It is no longer approved, and therefore not marketed, for any human use in the United States. In the UK it is used to treat ankylosing spondylitis, but only when other therapies are unsuitable.
Phenylbutazone may be administered orally (via paste, powder or feed-in) or intravenously. It should not be given intramuscularly or injected in any place other than a vein, as it can cause tissue damage. Tissue damage and edema may also occur if the drug is injected repetitively into the same vein. Phenylbutazone should be administered only under the advice of a veterinarian. References: | |||||
Phenylbutazone Dilution Calculator
Phenylbutazone Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 5.3763 mL | 26.8817 mL | 53.7634 mL | 107.5269 mL | 134.4086 mL |
| 5 mM | 1.0753 mL | 5.3763 mL | 10.7527 mL | 21.5054 mL | 26.8817 mL |
| 10 mM | 0.5376 mL | 2.6882 mL | 5.3763 mL | 10.7527 mL | 13.4409 mL |
| 50 mM | 0.1075 mL | 0.5376 mL | 1.0753 mL | 2.1505 mL | 2.6882 mL |
| 100 mM | 0.0538 mL | 0.2688 mL | 0.5376 mL | 1.0753 mL | 1.3441 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Phenylbutazone is used as a non-steroidal anti-inflammatory agent for the treatment of chronic pain, including the symptoms of arthritis.
- beta-Estradiol
Catalog No.:BCN2194
CAS No.:50-28-2
- Estriol
Catalog No.:BCN2235
CAS No.:50-27-1
- Prednisolone
Catalog No.:BCC4830
CAS No.:50-24-8
- Hydrocortisone
Catalog No.:BCN2192
CAS No.:50-23-7
- Corticosterone
Catalog No.:BCN2203
CAS No.:50-22-6
- Cyclophosphamide
Catalog No.:BCC1185
CAS No.:50-18-0
- Ergocalciferol
Catalog No.:BCN2208
CAS No.:50-14-6
- Mitomycin C
Catalog No.:BCC2388
CAS No.:50-07-7
- Cortisone acetate
Catalog No.:BCC4771
CAS No.:50-04-4
- Dexamethasone (DHAP)
Catalog No.:BCC1184
CAS No.:50-02-2
- Guanidine HCl
Catalog No.:BCC4785
CAS No.:50-01-1
- Tioxolone
Catalog No.:BCC2316
CAS No.:4991-65-5
- Thalidomide
Catalog No.:BCC2248
CAS No.:50-35-1
- Cocaine
Catalog No.:BCN1901
CAS No.:50-36-2
- Clomiphene citrate
Catalog No.:BCC4480
CAS No.:50-41-9
- Mercaptopurine (6-MP)
Catalog No.:BCC1186
CAS No.:50-44-2
- Estradiol Benzoate
Catalog No.:BCC4779
CAS No.:50-50-0
- Reserpine
Catalog No.:BCN4960
CAS No.:50-55-5
- Oxytocin
Catalog No.:BCC5435
CAS No.:50-56-6
- Chloroquine diphosphate
Catalog No.:BCC3915
CAS No.:50-63-5
- Niclosamide
Catalog No.:BCC5081
CAS No.:50-65-7
- 5-Hydroxytryptamine
Catalog No.:BCC9204
CAS No.:50-67-9
- 1,3:2,4-Di-p-methylbenyliedene sorbitol
Catalog No.:BCC4847
CAS No.:54686-97-4
- Actinomycin D
Catalog No.:BCC2385
CAS No.:50-76-0
The Analysis of Phenylbutazone and Its Active Metabolite, Oxyphenbutazone, in Equine Tissues (Muscle, Kidney, and Liver), Urine, and Serum by LC-MS/MS.[Pubmed:28145218]
J AOAC Int. 2017 Jul 1;100(4):1110-1122.
This study reports the use of two validated LC with tandem MS (MS/MS) methods to study the residue depletion profile of Phenylbutazone (PBZ) and its metabolite oxyphenbutazone (OXPBZ) from equine serum, urine, and muscle, kidney, and liver tissues. One LC-MS/MS method, with an LOQ of 1.0 ng/mL for PBZ and 2.0 ng/mL for OXPBZ, was used for the analysis of the two drugs in the biological fluids (equine urine and serum); the other LC-MS/MS method, with an LOQ of 0.5 ng/g for PBZ and OXPBZ, was used for the analysis of the drugs in the equine tissue samples. PBZ was administered intravenously to two horses dosed with 8.8 mg/kg PBZ once daily for 4 days and sacrificed humanely at a slaughter plant 7 days after the last drug administration. Urine, serum, and kidney, liver, and muscle tissues were collected from the two horses and shipped on ice to the laboratory and stored at -20 degrees C until analysis. The concentrations of PBZ and OXPBZ residues in the biological fluid and tissue samples collected at slaughter were measured with the two validated LC-MS/MS methods using deuterated internal standards. The results demonstrate that the validated methods are fit for studying the depletion kinetics of PBZ residues in equine tissues and biological fluids.
Comparative efficacy of oral meloxicam and phenylbutazone in 2 experimental pain models in the horse.[Pubmed:28216685]
Can Vet J. 2017 Feb;58(2):157-167.
The efficacy of oral Phenylbutazone [PBZ; 4.4 mg/kg body weight (BW), q12h], a non-selective non-steroidal anti-inflammatory drug (NSAID), and oral meloxicam (MXM; 0.6 mg/kg BW, q24h), a COX-2 selective NSAID, were evaluated in 2 experimental pain models in horses: the adjustable heart bar shoe (HBS) model, primarily representative of mechanical pain, and the lipopolysaccharide-induced synovitis (SYN) model, primarily representative of inflammatory pain. In the HBS model, PBZ reduced multiple indicators of pain compared with the placebo and MXM. Meloxicam did not reduce indicators of pain relative to the placebo. In the SYN model, MXM and PBZ reduced increases in carpal skin temperature compared to the placebo. Meloxicam reduced lameness scores and lameness-induced changes in head movement compared to the placebo and PBZ. Phenylbutazone reduced lameness-induced change in head movement compared to the placebo. Overall, PBZ was more effective than MXM at reducing pain in the HBS model, while MXM was more effective at reducing pain in the SYN model at the oral doses used.
Investigation of the role of environmental contamination in the occurrence of residues of the veterinary drug phenylbutazone in cattle.[Pubmed:28140763]
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2017 Apr;34(4):520-524.
Phenylbutazone is a non-steroidal anti-inflammatory drug licensed for use in horses to treat musculoskeletal disorders. It is not permitted in the European Union for use in animals destined for the food chain. Official statistics provided by the European Food Safety Authority (EFSA) show that 0.18% of bovines tested in the European Union between 2008 and 2014 for non-steroidal anti-inflammatory drugs were non-compliant, with Phenylbutazone representing over 28% of these. Anecdotal evidence suggests animals that have not been treated with the drug may have produced non-compliant samples, possibly through some form of contamination. In this study, ultra-high-performance liquid chromatography coupled with mass-spectrometric detection was applied to bovine plasma samples to determine if detectable residues (CCalpha = 0.28 ng ml(-1)) may occur in untreated animals as a result of environmental contamination through normal farming practice. The study demonstrates that waste from animals treated with Phenylbutazone, and spread on an area of pasture, can contaminate untreated bovines grazing the pasture many weeks later. It was determined that this contamination, which can persist over a significant period, may be due to the ingestion of as little as 30 mug Phenylbutazone by a 500 kg bullock.
